Nasacort AQ

Nasacort AQ

triamcinolone acetonide




Concise Prescribing Info
Triamcinolone acetonide
Nasal symptoms of seasonal & perennial allergic rhinitis in adults & childn ≥4 yr.
Dosage/Direction for Use
Adult & childn ≥12 yr Initially & max dose of 2 sprays in each nostril once daily (220 mcg/day). Childn 4-12 yr Initially 1 spray in each nostril once daily (110 mcg/day). Max: 2 sprays in each nostril once daily (220 mcg/day).
Special Precautions
Patients previously treated for prolonged periods w/ systemic corticosteroids. Closely monitor patients w/ change in vision or w/ history of increased IOP, glaucoma &/or cataracts. Visual disturbance may occur. Patients w/ active or quiescent tuberculous infections of the resp tract, untreated fungal, bacterial or systemic viral infections or ocular herpes simplex. Patients who experienced recent nasal septal ulcers, nasal surgery or trauma. Slowly discontinue treatment if systemic corticosteroid effects eg, hypercorticism & adrenal suppression appear (when used at excessive doses). Avoid exposure to chickenpox or measles. Pregnancy & lactation. Childn <4 yr; & those on immunosuppressants.
Adverse Reactions
Flu syndrome, pharyngitis, rhinitis; headache; bronchitis, epistaxis, cough; dyspepsia, tooth disorder.
ATC Classification
R01AD11 - triamcinolone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.
Additional Information
Exemptions granted for limited sale and supply without prescription:
As an intranasal spray containing not more than 55 mcg/actuation
Indication: Prevention and treatment of allergic rhinitis
Maximum daily dose: 220 mcg
Maximum supply: 3 months
Minimum age: 18 years
Nasacort AQ nasal spray 55 mcg/actuation
120 dose x 1's;30 dose x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in